Inclusion Criteria:  Diagnosis of Type 2 Diabetes with  Hemoglobin A1c above goal 6.5%-8% based on participant specific factors defined in the ADA guidelines (e.g. comorbidities and age) OR Identified glycemic excursions, including hypoglycemia based on documented blood glucose readings of < 70 mg/dL via point-of-care glucose testing, lab testing or self-monitoring or reported signs and symptoms of hypoglycemia documented in the medical record Referred and actively followed by pharmacy for at least 3 months prior to study enrollment Have at least one encounter with pharmacist within the last 3 months Have at least one A1c documented while under pharmacist care On at least one anti-diabetic medication Demonstrates willingness (at the discretion of the investigators) to scan the CGM several times a day Demonstrates willingness (at the discretion of the investigators) to attend regular office visits or phone calls  Exclusion Criteria:  Currently pregnant or actively trying to conceive Receiving dialysis Currently followed by the endocrinology clinic for diabetes Current or past CGM use in the last 6 months prior to study enrollment Participant meets criteria for insurance coverage of CGM Known allergy to medical adhesive Wearing any implanted medical device